Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial

Author(s):
Wortman, B.G.; Bosse, T.; Nout, R.A.; Lutgens, L.C.H.W.; Steen-Banasik, E.M. van der; Westerveld, H.; Berg, H. van den; Slot, A.; Winter, K.A.J. de; Verhoeven-Adema, K.W.; Smit, V.T.H.B.M. (0000-0003-3730-5652); Creutzberg, C.L. (0000-0002-7008-4321); PORTEC Study Grp
Published
2018
Publication type
Article / Letter to editor
Endometrial cancerRandomized trialBrachytherapyMolecular-integrated risk profilesRadiotherapyPrognostic factors
Date issued
2018-10-31
Language
English
Is part of
Gynecologic Oncology (2018), Vol. 151, no. 1, p. 69-75
hdl
1887/75544
doi
10.1016/j.ygyno.2018.07.020